Quantitative analysis for Adicet Bio, Inc. (ACET) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (69.0) (grade B). 30 signals analyzed (25 differentiated alt-data).
ACET stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $7.92 | $7.55 | $7.67 |
| 2026-05-08 | $8.90 | $8.35 | $8.55 |
| 2026-05-20 | $7.91 | $7.23 | $7.76 |
| 2026-06-02 | $8.67 | $8.11 | $8.11 |
| 2026-06-12 | $8.33 | $7.44 | $8.05 |
| 2026-06-25 | $8.30 | $7.88 | $7.90 |
| 2026-07-08 | $9.31 | $8.53 | $9.25 |
| 2026-07-20 | $8.13 | $7.76 | $7.89 |
| 2026-07-30 | $9.11 | $8.33 | $9.06 |
| 2026-08-12 | $8.35 | $8.18 | $8.26 |
| 2026-08-24 | $9.21 | $8.76 | $8.90 |
| 2026-09-03 | $9.64 | $9.05 | $9.43 |
How Adicet Bio, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| QTTB | Q32 Bio Inc. | $72M | — |
| CYPH | Cypherpunk Technologies Inc. | $72M | 38.0 |
| EQ | Equillium, Inc. | $73M | — |
| RANI | Rani Therapeutics Holdings, Inc. | $71M | — |
View all Health Care stocks by valuation and signals →
Adicet Bio, Inc. (ACET) scores Buy (69.0), and the composite conceals a 99-point disagreement between its dimensions. It is strongest on technicals at 99 and ML forecast at 88, and weakest on analyst consensus at 0. A stock can carry technicals that high while analyst consensus sits at 0; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 99 |
| ML forecast | 88 |
| competitive moat | 87 |
| analyst consensus | 0 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Adicet Bio, Inc. (ACET): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ACET"><img src="https://stoquant.com/badge/ACET.svg" alt="Adicet Bio, Inc. (ACET) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.